Initial Clinical Experiences With Novel Diagonal ECLS System in Pediatric Cardiac Patients

• DOI: 10.1111/aor.12977
• Publication Date: 2017-08-07T08:55:09Z
• Authors: Yildiz Okan; Haydin Sertac; Ozturk Erkut; Kasar Taner; Onan I. Selen; Altin H. Firat; Cine Nihat; Ayyildiz Pelin; Erkan Halime; Guzeltas Alper
• Keywords: Extracorporeal; Life support

Abstract Extracorporeal life support (ECLS) provides mechanical following cardiac surgery when respiratory or failure occurs. The aim of this study was to analyze the safety and feasibility Medos Deltastream diagonal pump (DP3) ECLS system in pediatric patients. We described technical considerations risk factors related survival outcomes 102 patients who received between March 2011 April 2016. switched from DP2 system, which used for initial 25 patients, DP3 after November 2012. then a consecutive series 77 (4.5% all underwent congenital heart during same time period). patients’ median age 90 days (range: 2 days–12 years), while their weight 4 kg 2.1–40 kg). Fifty four (70%) were weaned off ECLS, 28 (36.3%) successfully discharged hospital by means system. duration survivors 8.2 4–14.5 days). indications, durations, initiation times had no statistical significance terms survival. Renal, hemorrhagic, neurologic complications associated with decreased discharge rates ( P = 0.003, 0.045, < 0.001 respectively). Higher lactate levels 0.009) longer normalization 0.001) both wean and, hence, deaths. weaning rate 36% prior It increased 70.3% that 0.009). complication 9% 32% DP2, statistically significant Additionally, higher more slowly supported DP2. As result shift revised protocol, experience, improvement observed our clinical outcomes. results suggested combination Hilite oxygenator circuits may improve durability reduce circuit‐induced complications.